News from CROI 2015

The annual Conference on Retroviruses and Opportunistic Infections (CROI 2015) is taking place in Seattle, USA, in late February.

Our writers will be reporting on key research presented at the conference, publishing news and sending out CROI news summary bulletins by email, three during the conference week and one the following week.

“The coverage made me feel I was at the conference and I appreciate NAM's effort in sharing the bulletins.” NAM bulletin subscriber

aidsmap news from CROI 2015

Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use

Among some highly promising results from HIV prevention studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA, today, there was

Published
25 February 2015
By
Gus Cairns
7-country study shows triple-drug combination superior for preventing infant HIV infection

Implementing the World Health Organization (WHO) recommendation of three-drug antiretroviral treatment during pregnancy leads to a significantly lower rate of mother-to-child HIV transmission, a 7-country randomised study has

Published
25 February 2015
By
Keith Alcorn
Breastfeeding mothers often undiagnosed in sub-Saharan Africa

A large proportion of women in sub-Saharan Africa who are at high risk of transmitting HIV to their infants during breastfeeding are likely still to be undiagnosed,

Published
25 February 2015
By
Keith Alcorn
Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study

A French and Canadian study of pre-exposure prophylaxis (PrEP) presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA, found that

Published
24 February 2015
By
Gus Cairns
Pre-exposure prophylaxis (PrEP) stops 86% of HIV infections in PROUD study

A study of pre-exposure prophylaxis (PrEP), the English PROUD study, demonstrated the highest effectiveness yet seen for this method of HIV prevention, the Conference on Retroviruses and

Published
24 February 2015
By
Gus Cairns
← Prev12345Next →

Email bulletins

Sign up for our conference bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.